@article{ed180eb3ba504c11bb4d881f363eca28,
title = "Cilostazol and isosorbide mononitrate for the prevention of progression of : baseline data and statistical analysis plan for the Lacunar Intervention Trial-2 (LACI-2) (ISRCTN14911850)",
author = "Bath, {Philip M} and Iris Mhlanga and Woodhouse, {Lisa J} and Fergus Doubal and Katherine Oatey and Montgomery, {Alan A} and Wardlaw, {Joanna M}",
note = "Funding Information: The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This work is supported by British Heart Foundation (CS/15/5/31475), the Alzheimer{\textquoteright}s Society (AS-PG-14–033), EU Horizon 2020 SVDs@Target (666881), MRC UK DRI, Fondation Leducq (16/05 CVD), NHS Research Scotland, The Stroke Association and Garfield-Weston Foundation, Chief Scientist Office (UC), and National Institute of Health Research. PMB is Stroke Association Professor of Stroke Medicine and an Emeritus NIHR Senior Investigator. Publisher Copyright: {\textcopyright} Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.",
year = "2022",
month = sep,
day = "2",
doi = "10.1136/svn-2022-001816",
language = "English",
pages = "svn--2022--001816",
journal = "Stroke and Vascular Neurology",
issn = "2059-8696",
publisher = "BMJ Publishing Group",
}